* Deal deepens oncology push under CEO Luke Miels
* Deal deepens oncology push under CEO Luke Miels
June 9 (Reuters) - Britain's blue-chip FTSE 100 hit its lowest since mid-May on Tuesday, bogged down by losses in heavyweight lenders HSBC and Standard Chartered, while energy giants also lost gr...
* Deal values cancer drug developer Nuvalent at $124 per share